Metabolic Syndrome Is Associated With Poor Prognosis in Patients With Breast Cancer Receiving Neoadjuvant Therapy
MetS was associated with poor prognosis in patients with breast cancer receiving NAT. Hence, close attention should be paid to patients with breast cancer who have MetS.
Authors
- Xiuchun Chen (ORCID: https://orcid.org/0000-0002-7134-7170)
- Jingyang Zhang (ORCID: https://orcid.org/0000-0002-4347-9416)
- Youzhao Ma (ORCID: https://orcid.org/0000-0002-6056-5703)
- Dechuang Jiao (ORCID: https://orcid.org/0009-0003-7441-9103)
- Zhenzhen Liu
Institutions
- Zhengzhou University (CN)
- Henan Cancer Hospital (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/cam4.70484
- Primary Topic
- Cancer Risks and Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Science and Technology Department of Henan Province